MedPath

南光化學製藥股份有限公司

Ownership
-
Established
1973-08-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Linezolid and Glucose Injection

Product Name
利奈唑胺葡萄糖注射液
Approval Number
国药准字HC20240008
Approval Date
Nov 5, 2024
NMPA

Glycerol Fructose and Sodium Chloride Injection

Product Name
固利压
Approval Number
国药准字HC20170004
Approval Date
Dec 31, 2021
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字HC20160039
Approval Date
Nov 22, 2021
NMPA

Lansoprazole Enteric-coated Capsules

Product Name
拉索脱
Approval Number
国药准字HC20160028
Approval Date
Jul 22, 2021
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字HC20150042
Approval Date
Oct 20, 2020
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字HC20150040
Approval Date
Oct 20, 2020
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字HC20150041
Approval Date
Oct 20, 2020
NMPA

Glycerol Fructose and Sodium Chloride Injection

Product Name
甘油果糖氯化钠注射液
Approval Number
HC20140027
Approval Date
Feb 4, 2020
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath